More on ABUS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.8 Score)
- Holders

Upcoming Events

- Earnings (5/14/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Arbutus Biopharma (NQ:ABUS)
Delayed: 4.53 -0.17 (3.62%)
Prev. Close $4.70  
Open$4.59 
52 Wk High$5.88 
52 Wk Low$2.65 
Day High$4.67 
Day Low$4.46 
P/E N/A  
EPS$0.00 
Volume3,371,699 

Friends, Peers and Foes (?): ROIV, MRNA, BGS, BOX, CRWD (more...)

Mar 5, 2026 04:45 AM Increasing unusual option volume: DINO CTMX ABUS RYAM EWY AMPY PBF ODD BNO
Mar 4, 2026 09:52 AM Increasing unusual option volume: ABUS GLNG COUR EWY BGS BOX TECK WTI EXAS FSLY ROST FLNG LASR
Mar 4, 2026 09:21 AM Chardan Reiterates Buy Rating on Arbutus Biopharma (ABUS) Following Moderna Settlement
Mar 3, 2026 04:33 PM After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
Mar 3, 2026 04:21 PM Form 8-K Arbutus Biopharma Corp For: Mar 03
Mar 3, 2026 04:16 PM Roivant's Genevant and Arbutus reach $2.25 billion settlement with Moderna
Mar 3, 2026 04:15 PM Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna
Mar 3, 2026 04:15 PM Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
Feb 20, 2026 04:02 PM Form 8-K Arbutus Biopharma Corp For: Feb 17
Feb 17, 2026 04:22 PM Form SCHEDULE 13G/A Arbutus Biopharma Corp Filed by: Two Seas Capital LP
View All Articles

Entities mentioned with ABUS

View All Entities